Pharmafile Logo
Pharmafocus logo
Advanced Search

GSK gambles on success of new European pricing deal

September 25, 2006
Sales and Marketing EU, GSK

GlaxoSmithKline has unveiled a new deal which could break the deadlock over the pricing of medicines in Europe.The groundbreaking agreement …

News

Gardasil approved in Europe

September 22, 2006
Sales and Marketing Gardasil

Sanofi Pasteur MSD's Gardasil has been approved as the first ever vaccine to prevent women developing cervical cancer, which remains …

News

Specialist pharma company Nycomed buys Altana

September 22, 2006
Sales and Marketing Nycomed

Danish speciality pharmaceutical company Nycomed is to acquire pharma company Altana for 4.5 billion euros.Germany's Altana is currently a business …

News

New diabetes drug Byetta set for European approval

September 22, 2006
Sales and Marketing Byetta, diabetes

Lilly and Amylin's new diabetes treatment Byetta is set for European approval following recommendation from medicines regulator the EMEA.Byetta (exenatide) …

News

Merck to buy Serono for $13 billion

September 22, 2006
Sales and Marketing Merck Serono

German pharma company Merck is to acquire Serono for $13.5 billion, creating one of Europes largest bio-pharmaceutical technology companies.The new …

News

AZ and Schering take novel approach in cancer collaboration

September 22, 2006
Research and Development

AstraZeneca and Schering are to co-develop a promising new drug candidate to treat breast cancer, with the two partners taking …

News

Integrated Huntsworth Health moves into top tier

September 22, 2006
Medical Communications

Healthcare communications group Huntsworth has merged its advertising, medical education and PR agencies into a single, fully integrated company, to …

News

Waving not drowning: tackling NHS reform

September 18, 2006
Sales and Marketing NHS, healthcare, marketing, strategy

New NHS initiatives, restructuring plans and government health policies seem to be announced and introduced on a never-ending basis, with …

Feature

NHS preparing to cut A&E and maternity units

September 14, 2006

The new chief executive of the NHS, David Nicholson, is drawing up plans to close a series of key hospital …

News

Lipitor patients sue Pfizer

September 14, 2006
Sales and Marketing patients

A series of personal injury lawsuits filed in the US have taken aim at Pfizer's marketing practices for its blockbuster …

News

PCTs to retain clinical leadership role

September 13, 2006

Professional executive committees, the bodies once seen as the engine room for reform of the NHS, are to be retained …

News

DHL deal ‘catastrophic’ for UK medical devices industry

September 13, 2006

DHL's new contract to manage procurement across the NHS threatens the future of UK medical devices firms, according to manufacturers. …

News

Dolan forced out over Plavix affair

September 13, 2006
Sales and Marketing ethics

Peter Dolan, the chief executive of Bristol-Myers Squibb has been forced to resign after the company's legal advisor called for …

News

New PCTs to tighten general practice prescribing controls

September 12, 2006

Moves to rein in the prescribing freedom of GPs and give prescribing advisors more power are gaining ground in the …

News

A fresh look at advertising

September 11, 2006
Medical Communications advertising

Mary Poppins knew only too well that a spoonful of sugar makes the medicine go down. But in these sugar-free …

Feature

NICE takes aim at ineffective treatments

September 7, 2006

NICE is to review use of ineffective treatments by the NHS with the aim of saving millions of pounds – …

News

Public affairs agency Advocate launched

September 7, 2006
Medical Communications

A former Labour Party press officer has launched the first independent public affairs agency dedicated exclusively to healthcare.Camden-based Advocate's managing …

News

NicOx to develop enhanced statin product

September 6, 2006
Research and Development

NicOx is to develop a new statin treatment using its special in-house technology which, according to the company, could make …

News

Collaboration to develop new Parkinson’s Disease dyskinesia treatment

September 6, 2006
Research and Development

Santhera Pharmaceuticals is collaborating with Finnish biotech company Juvantia Pharma to develop a treatment for dyskinesia, the distressing involuntary movements …

News

Think-tank calls for new cancer strategy

September 6, 2006

Health think-tank the King's Fund has called for a fundamental re-examination in the way NHS cancer services are provided in …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026